Factors affecting patient adherence to highly active antiretroviral therapy
dc.contributor.author | Escobar, Ismael | |
dc.contributor.author | Campo, Mercedes | |
dc.contributor.author | Martín , Jesús | |
dc.contributor.author | Fernández-Shaw, Clara | |
dc.contributor.author | Pulido, Federico | |
dc.contributor.author | Rubio, Rafael | |
dc.date.accessioned | 2025-01-07T08:07:00Z | |
dc.date.available | 2025-01-07T08:07:00Z | |
dc.date.issued | 2003-06 | |
dc.description | This project was supported by a grant from Foundation for the In vestigation and Prevention of AIDS in Spain, expedient no. 2109/00 | |
dc.description.abstract | Objective: To determine the clinical and demographic variables related to adherence to highly active antiretroviral therapy (HAART) in patients treated in our hospital and identify the characteristics of nonadherent patients. Methods: Outpatients receiving treatment with HAART (n = 283) were asked about variables related to adherence and to complete the APGAR (family support), State-Trait Anxiety questionnaire (STAI) (emotional situation), and IAS (social support) questionnaires. Patients were classified in 2 groups depending on whether adherence was > or =95% or <95%. Adherence was defined as the percentage of dosage forms prescribed that were obtained by the patient at the hospital pharmacy. A multivariate analysis was created to analyze how each significant variable affected adherence. Results: Our data showed significant nonadherence for patients with the following factors: low level of education, unemployed, emotional situation, and abuse of substances including intravenous drugs. All significant variables were included in a logistic regression model to optimize the results. This model considered 4 variables: age (95% CI 0.89 to 0.99), number of antiretroviral drugs (95% CI 1.05 to 2.11), STAI Anxiety/Trait test (95% CI 2.02 to 6.02), and abuse of drugs (95% CI 1.20 to 3.95). Conclusions: We recommended special intervention to reinforce adherence for younger patients, patients taking a high number of antiretroviral drugs, those who have a history of intravenous drug use, and those with high anxiety status. | |
dc.identifier.citation | Escobar I, Campo M, Martín J, Fernández-Shaw C, Pulido F, Rubio R. Factors Affecting Patient Adherence to Highly Active Antiretroviral Therapy. Annals of Pharmacotherapy. 2003;37(6):775-781. doi:10.1345/aph.1C427 | |
dc.identifier.doi | 10.1345/aph.1C427 | |
dc.identifier.issn | 1060-0280 | |
dc.identifier.uri | https://hdl.handle.net/10115/50577 | |
dc.language.iso | en | |
dc.publisher | SAGE | |
dc.rights.accessRights | info:eu-repo/semantics/closedAccess | |
dc.title | Factors affecting patient adherence to highly active antiretroviral therapy | |
dc.type | Article |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Annals_pharmacotherapy 2003.pdf
- Tamaño:
- 64.04 KB
- Formato:
- Adobe Portable Document Format